Masataka Hirasaki
Overview
Explore the profile of Masataka Hirasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawasaki T, Tashima T, Onohara K, Hirano Y, Yamato M, Shirotake S, et al.
Front Oncol
. 2024 Nov;
14:1425809.
PMID: 39588302
Dedifferentiated liposarcoma is a malignant lipomatous tumor that rarely occurs in the gastrointestinal tract, including the ileocecal region. In this case, computed tomography and magnetic resonance imaging showed no fatty...
2.
Sonoda Y, Hirasaki M, Usami Y, Torigoe T, Kawasaki T, Suzuki N, et al.
Radiol Case Rep
. 2024 Sep;
19(11):4963-4969.
PMID: 39247466
We present a case of pulmonary metastasis originating from renal angiomyolipoma (AML), as evidenced by whole-exome sequencing (WES) analysis. Although AML predominantly arises in the kidneys, it can emerge in...
3.
Nogi T, Uranishi K, Suzuki A, Hirasaki M, Nakamura T, Kazama T, et al.
PLoS One
. 2024 Mar;
19(3):e0298264.
PMID: 38547201
Although sevoflurane is one of the most commonly used inhalational anesthetic agents, the popularity of desflurane is increasing to a level similar to that of sevoflurane. Inhalational anesthesia generally activates...
4.
Takenaka Y, Hirasaki M, Bono H, Nakamura S, Kakinuma Y
J Cardiovasc Pharmacol
. 2024 Feb;
83(5):433-445.
PMID: 38422186
We previously reported a novel compound called S-nitroso- N -pivaloyl- d -penicillamine (SNPiP), which was screened from a group of nitric oxide donor compounds with a basic chemical structure of...
5.
Mihara Y, Hirasaki M, Horita Y, Fujino T, Fukushima H, Kamakura Y, et al.
BMC Gastroenterol
. 2024 Feb;
24(1):67.
PMID: 38321412
No abstract available.
6.
Mihara Y, Hirasaki M, Horita Y, Fujino T, Fukushima H, Kamakura Y, et al.
BMC Gastroenterol
. 2023 Nov;
23(1):373.
PMID: 37907839
No abstract available.
7.
Mihara Y, Hirasaki M, Horita Y, Fujino T, Fukushima H, Kamakura Y, et al.
BMC Gastroenterol
. 2023 Oct;
23(1):339.
PMID: 37784019
Background: Fluoropyrimidine-based postoperative adjuvant chemotherapy is globally recommended for high-risk stage II and stage III colon cancer. However, adjuvant chemotherapy is often associated with severe adverse events and is not...
8.
Ichinose Y, Hasebe T, Hirasaki M, Sakakibara A, Yokogawa H, Nukui A, et al.
Pathol Int
. 2023 Jun;
73(9):413-433.
PMID: 37378453
Vimentin is a stable mesenchymal immunohistochemical marker and is widely recognized as a major marker of mesenchymal tumors. The purpose of the present study was to investigate if the vimentin...
9.
Inoue H, Hirasaki M, Kogashiwa Y, Nakachi Y, Kuba K, Ebihara Y, et al.
Clin Exp Dent Res
. 2023 Jun;
9(4):711-720.
PMID: 37272305
Objectives: In recent years, an increase in oral cancer among elderly nonsmokers has been noted. The aim of this study was to identify novel oncogenes in oral cancer in older...
10.
Takenaka Y, Inoue I, Hirasaki M, Ikeda M, Kakinuma Y
FEBS J
. 2023 Apr;
290(15):3843-3857.
PMID: 37002713
We previously developed a stress-induced premature senescence (SIPS) model in which normal human fibroblast MRC-5 cells were treated with either the proteasome inhibitor MG132 or the vacuolar-type ATPase inhibitor bafilomycin...